Regular Screenings for Ovarian Cancer May Reduce Mortality Rate for Women
For many women, ovarian cancer is a death sentence, as doctors most often detect it in the later stages of the disease when treatment options are less effective. Approximately 60 percent of patients diagnosed with ovarian cancer die within five years. In order to reduce these figures, doctors are promoting more annual screenings for women.
The United Kingdom Collaborative Trial of Ovarian Cancer Screening compiled data from 202,638 women in the UK, ages 50-74. Of these participants, 101,299 had no screenings for ovarian cancer, while 50,623 had an annual ultrasound and 50,624 had both an annual ultrasound and a blood test. Researchers recruited the women between 2001 and 2005. The screenings started in 2001 and ended in 2011. The researchers continued to monitor the health and progress of each participant through 2014.
Of the more than 200,000 participants, 1,282 developed ovarian cancer during the average 11.1-year follow-up period. Six hundred thirty cancer cases occurred in the women who did not receive screening for ovarian cancer, 314 occurred in women who had annual ultrasounds, and 338 occurred in women who had annual ultrasounds and blood tests.
When compared to the unscreened group, the mortality rate was 11 percent lower for women who had annual ultrasounds and 15 percent for ultrasound and blood test screening. Early detection plays a key role in the prognosis of ovarian cancer treatment, progression, and relapse.
If You Can No Longer Work Due to Cancer Treatment, You May Qualify For Disability Benefits
The treatments for ovarian cancer can include invasive surgery, chemotherapy, and radiation. Any of these procedures can cause a woman to no longer be able to work and earn her regular income. If this has happened to you or a loved one, contact the Disability Help Group or call us at 1-(800)-800-3332 to learn about your options for Social Security disability benefits.